News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Scheer Partners, Inc. Engaged by Novavax, Inc. (NVAX) to Sublease State-of-the-Art, 51,200-Square-Foot Biotech Lab and Manufacturing Facility in Rockville



9/4/2012 1:36:26 PM

Rockville, MD (September 4, 2012) – Further demonstrating its diverse range of services and loyal client base, Scheer Partners is assisting Novavax’s efforts to secure tenancy for its Rockville facility only a few months after representing the vaccine maker in acquiring approximately 75,000 square feet of space in nearby Gaithersburg.

Scheer Partners, the leading provider of fully integrated commercial real estate services for the health science industry in the Washington and Baltimore metropolitan areas, announces today its hiring by Novavax to sublease 9920 Belward Campus Drive, a two-story, 51,200-square-foot biomanufacturing, R&D and office building.

Robert Scheer, the founder and president of Scheer Partners, Henry Bernstein, a senior vice president, and Matt Brady, a vice president, are handling the marketing responsibilities for 9920 Belward Campus Drive, which is owned by San Diego-based BioMed Realty Trust and represents one of the biggest blocks of contiguous biotech space now on the market in the D.C. region.

“This facility is strategically situated within the Rockville submarket – ground zero for biotech activity along the Interstate 270 technology corridor,” Brady says. “Presently, there are limited opportunities of this size, and this is one of the best options in the marketplace.

“For biopharmceutical companies looking to add another location or occupy manufacturing and R&D space, rather than build a facility from scratch, 9920 Belward Campus Drive makes a lot of sense,” he adds. “A mid-stage firm ready to step-up to the next level is an ideal user.”

Among the building’s features are a cGMP pilot-scale biomanufacturing suite; lab space with metal casework and epoxy resin benches; lab services such as an autoclave and a glass wash; a central vacuum and central-compressed air systems; walk-in cold rooms; conference rooms; a large kitchenette and eating area; and existing office furniture available for purchase.

The building, which can be leased in its entirety or by individual floors, will be available for occupancy by a new subtenant in the first quarter of 2013.

Novavax and Scheer Partners have a multi-year history of collaborating on real estate projects. Late last year, Scheer Partners announced that it had negotiated for Novavax a long-term lease of 74,209 square feet of biomanufacturing, R&D and office space at 20 and 22 Firstfield Road in Gaithersburg.

The Rockville-based commercial real estate firm also represented the clinical-stage vaccine manufacturer on its current lease at 9920 Belward Campus Drive. Says Scheer: “We are excited that Novavax, an extremely promising biopharmaceutical vaccine company, has once again chosen to work with us and rely on our expertise to meet its needs.”

About Scheer Partners:

Founded in 1991, Scheer Partners is a full-service commercial real estate firm headquartered in Rockville, Md. With a focus on the greater Washington and Baltimore regions, Scheer Partners’ fully integrated services include tenant and landlord representation; strategic planning consulting; facilities and construction management; and investment sales, acquisitions and development. While the firm works with clients across all industry types, Scheer Partners is the recognized leader serving the health-care market, with more than 500 successful projects in this sector. Scheer Partners is the operations manager for Montgomery County's technology incubator program, which has more than 160 tenants, and is co-manager of the Greater Washington Life Sciences Fund. The company’s Web site is www.scheerpartners.com.

For more information, please contact:

Neil Adler of D*MNGOOD®

202-683-8975 (office)

410-499-5004 (cell)

neil.adler@dmngood.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES